STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)											1 Months Ended			2 Months Ended	3 Months Ended				6 Months Ended		12 Months Ended
	Mar. 17, 2021	Feb. 28, 2021	Feb. 24, 2021	Feb. 11, 2021	Jan. 25, 2021	Nov. 22, 2020	Sep. 25, 2020	Jul. 21, 2020	Jul. 06, 2020	Feb. 05, 2020	Dec. 31, 2020	Jul. 31, 2020	Apr. 30, 2020	Jun. 17, 2020	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020	Jul. 22, 2020	Jul. 17, 2020	Jul. 08, 2020	Jun. 19, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, par value											$ 0.0001				$ 0.0001		$ 0.0001		$ 0.0001		$ 0.0001
Cash proceeds																			$ 58,269,829	$ 6,455,992
Shares issued during conversion
Shares issued for exercised stock options, shares															$ 1,041,491	$ 183,425
Shares issued for exercised stock options																			469,576
Share based compensation																			$ 3,337,494	$ 307,408
Preferred stock, designated											20,000,000				20,000,000		20,000,000		20,000,000		20,000,000
Warrant exercise price											$ 8.03				$ 7.37		$ 8.03		$ 7.37		$ 8.03
Exercise of warrants																		$ 515,338
Warrant outstanding											3,501,014				6,108,823		3,501,014		6,108,823		3,501,014
Expected volatility																				4.40%
Risk-free interest rate																				0.70%
Advisors [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued																					1,037,496
Merger Sub [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued																					2,337,663
Value of common stock issued																					$ 3,060,740
Restricted Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Value of common stock issued																			$ 681,725
Restricted Stock [Member] | Long-Term Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued																					1,087,618
Weighted average price restricted stock											$ 5.27						$ 5.27				$ 5.27
Number of shares vested																					15,115
Share based compensation															$ 1,407,012				2,836,541
Restricted Stock [Member] | Core IR [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued											15,000
Restricted Stock [Member] | Core IR [Member] | General and Administrative Expense [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Offering expenses																					$ 42,300
Restricted Stock [Member] | Director [Member] | 2020 Long-Term Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of restricted stock units			172,000
Offering price			$ 7.66
AYRO Seed Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Offering expenses																			$ 0	$ 36,760
Warrants to purchase common stock															461,647				461,647
Warrant exercise price															$ 7.33				$ 7.33
Warrants term															5 years				5 years
Exercise of warrants																			$ 100,000
Exercise of warrants, Shares																			13,642
AYRO Seed Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock															448,005				448,005
Series I Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock															14,636				14,636
Warrant exercise price															$ 69.00				$ 69.00
Warrants description																			If at any time (i) the volume weighted average price (“VWAP”) of the Common Stock exceeds $138.00 for not less than the mandatory exercise measuring period; (ii) the daily average number of shares of Common Stock traded during the mandatory exercise measuring period equals or exceeds 25,000; and (iii) no equity conditions failure has occurred as of such date, then the Company shall have the right to require the holder to exercise all or any portion of the Series I Warrants.
Warrant weighted average exercise price															$ 138.00				$ 138.00
Warrant outstanding															14,636				14,636
Series H-3 Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock															2,800				2,800
Warrant exercise price															$ 165.60				$ 165.60
Warrants term															5 years				5 years
Warrant outstanding															2,800				2,800
Series H-4 Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock															37,453				37,453
Warrant exercise price															$ 15.60				$ 15.60
Warrant outstanding															37,453				37,453
Anti-dilution price protection price per share															$ 15.60				$ 15.60
Series J Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock															52,023				52,023
Warrant exercise price															$ 30.00				$ 30.00
Warrants description																			If at any time (i) the VWAP of the Common Stock exceeds $9.00 for not less than the mandatory exercise measuring period; (ii) the daily average number of shares of Common Stock traded during the mandatory exercise measuring period equals or exceeds 25,000; and (iii) no equity conditions failure has occurred as of such date, then the Company shall have the right to require the holder to exercise all or any portion of the Series J Warrants still unexercised for a cash exercise.
Warrant weighted average exercise price															$ 45.00				$ 45.00
Warrant outstanding															52,023				52,023
Series H-5 Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock															296,389				296,389
Warrant exercise price															$ 2.50				$ 2.50
Warrants term															5 years				5 years
Exercise of warrants, Shares																			173,091
Warrants description																			The H-5 Warrants are entitled to certain anti-dilution adjustments if the Company issues shares of its common stock at a lower price per share than the applicable exercise price (subject to a floor of $0.792 per share). An anti-dilution adjustment was triggered resulting in an adjusted exercise price per share from $3.96 to $2.50, resulting in an issuance of an additional 173,091 warrants that are exercisable at $2.50 per share.
Warrant outstanding															348,476				348,476
Deemed dividend																			$ 432,727
Fair value of warrants																			967,143
Fair value of modification of orinigal award																			$ 534,416
Expected volatility																			89.96%
Dividend yield																			0.00%
Risk-free interest rate																			0.24%
Series I, H-1, H-3, H-4, J and H-5 [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrant expiration description																			Warrants expire through the years 2022-2024
June Finder Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock																									27,273
Warrant exercise price																									$ 2.75
Warrants term																									5 years
June Placement Agent Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock																									126,000
Warrant exercise price																									$ 2.875
July 8 Finder Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock															71,770				71,770					71,770
Warrant exercise price																								$ 5.225
July 8 Placement Agent Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock																								147,368
Warrant exercise price																								$ 5.4625
Warrants term																								5 years
July 22 Placement Agent Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock															129,500				129,500			129,500
Warrant exercise price																						$ 5.750
Warrants term																						5 years
September Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock							31,348
Share based compensation																	$ 66,845
Warrant exercise price							$ 3.19
Warrant outstanding							31,348
Warrant expiration description							The September Warrant is immediately exercisable and expires on September 25, 2025.
Decrease in exercise price							$ 2.13
November Finder Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock						56,256
Warrant exercise price						$ 6.6660
Warrant outstanding															56,256				56,256
November Placement Agent Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock						57,756									57,756				57,756
Warrant exercise price						$ 6.9690
Warrants description						The November Finder Warrants and November Placement Agent Warrants terminate after a period of 5 years on November 22, 2025.
February Finder Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock				15,574											51,459				51,459
Warrant exercise price				$ 10.925
February Placement Agent Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock				255,584											255,584				255,584
Warrants term				5 years
Series H-6 Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued												225,590
Shares issued during conversion, shares												7,833
Series H-3 Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock stated value															$ 138				$ 138
Aggregate issued and outstanding shares percentage															9.99%				9.99%
Series H Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock stated value															$ 154				$ 154
Preferred stock, conversion price																			$ 184.80
Aggregate issued and outstanding shares percentage															9.99%				9.99%
Series H-6 Convertible Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock stated value										$ 72.00
Preferred stock, conversion price										$ 3.60									$ 3.60
Aggregate issued and outstanding shares percentage										9.99%
Preferred stock, designated										50,000
Preferred stock, conversion price description										Each share of Series H-6 Preferred Stock is convertible at any time at the option of the holder thereof, into a number of shares of common stock of the Company determined by dividing the H-6 Stated Value by the initial conversion price of $3.60 per share, which was then further reduced to $2.50 under the anti-dilution adjustment provision, subject to a 9.99% blocker provision.
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued																					5,074,645
Shares issued during conversion, shares																		2,007,193
Warrants to purchase common stock											5,092,806						5,092,806				5,092,806
Cash proceeds																					$ 3,926,818
Shares issued during conversion																		$ 201
Shares issued for exercised stock options, shares															$ 39	$ 7
Shares issued for exercised stock options															394,589	74,987
Exercise of warrants																		$ 183
Exercise of warrants, Shares																		1,831,733
Common Stock [Member] | February Finder Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock				35,885
Warrant exercise price				$ 10.45
Common Stock [Member] | Series H-3 Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued																					795
Shares issued during conversion, shares																					955
Preferred stock, conversion price																			$ 165.60
AYRO Seed Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued																					2,007,193
Shares issued during conversion, shares																					7,360,985
Securities Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued				4,400,001	3,333,334	1,650,164
Common stock, par value					$ 0.0001
Proceeds from sale of common stock				$ 41,800,008	$ 20,000,004	$ 10,000,000		$ 1,512,500
Offering expenses				$ 3,394,054	$ 1,648,608	847,619
Shares issued for exercised stock options, shares		$ 13,642																	$ 469,576
Shares issued for exercised stock options		100,000																	1,224,917
Offering price					$ 6.00
Warrant exercise price					$ 6.93
Warrant purchase price					$ 233,334
Securities Purchase Agreement [Member] | Series A Warrants and Series B [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Value of common stock issued						$ 9,999,997
Securities Purchase Agreement [Member] | Series A Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock						1,237,624
Warrant exercise price						$ 8.09
Securities Purchase Agreement [Member] | Series B Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase common stock						825,084
Warrant exercise price						$ 8.90
Securities Purchase Agreement [Member] | January 2021 Offering [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued					3,333,334
Warrant exercise price					$ 6.93
Securities Purchase Agreement [Member] | Additional Shares [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued																					420,000
Common stock, par value				$ 0.0001	0.0001	0.0001		$ 0.0001			$ 0.0001						$ 0.0001				$ 0.0001
Offering price				$ 9.50	$ 6.00	$ 6.06		$ 5.00			5.00						5.00				$ 5.00
Proceeds from sale of common stock																					$ 2,100,000
Offering expenses																					168,000
Purchase of additional shares description	(i) sell up to 5% of such stockholder’s holdings in the Company’s common stock on any trading day (with such 5% limitation to be measured as of the date of each sale) and (ii) allow for unlimited sales of the Company’s common stock for any sales made at $10.00 per share or greater.			Each purchaser was also granted an option to purchase, on or before February 16, 2022, additional shares of common stock equal to the full amount of 75% of the common stock it purchased at the initial closing, or an aggregate of 3,300,001 shares, at an exercise price of $11.50 per share.				Each purchaser also had the right to purchase, on or before October 19, 2020, additional shares of common stock (the “Additional Shares”) equal to the full amount of 75% of the common stock it purchased at the initial closing, or an aggregate of 1,387,500 shares, at an offering price of $5.00 per share.
Shares issued for exercised stock options, shares																					$ 6,817
Shares issued for exercised stock options																					16,669
Securities Purchase Agreement [Member] | Investor [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued				3,300,001
Number of stock sold								1,850,000	3,157,895					2,200,000
Common stock, par value								$ 0.0001	$ 0.0001														$ 0.0001
Offering price								$ 5.00	$ 4.75														$ 2.50
Proceeds from sale of common stock								$ 9,250,000	$ 15,000,000					$ 5,500,000
Offering expenses								$ 740,000	$ 1,249,200					$ 435,000
Securities Purchase Agreement [Member] | Investor [Member] | Additional Shares [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Offering price				$ 11.50
Stock Purchase Agreements [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued																					1,573,218
Common stock, par value											$ 0.0001						$ 0.0001				$ 0.0001
Offering expenses																					$ 609,010
Cash proceeds																					$ 2,000,000
Bridge Notes [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued													553,330
Value of common stock issued													$ 600,000
Convertible Bridge Notes [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares issued during conversion, shares																					1,030,585
Shares issued during conversion																					$ 1,000,000